• @mvuviA
    link
    13 years ago

    Science and technology are not value neutral. It is driven by ideas of value, in this case profit:

    But although this new therapy is extremely promising, there are still numerous barriers to delivering this care, one of them being cost. Therapies for rare diseases aren’t profitable, so all this is funded by donations, fund raising and charities, with many other children waiting for treatment.